Skip to main content

Protein Modeling and Structure-Based Drug Design

  • Reference work entry
Drug Design

Abstract

Structure-based drug design focuses on the search, design, and optimization of a small molecule that fits well into the binding pocket of a target protein to form energetically favorable interactions. Initially, a detailed analysis of the protein is performed. All information about its structure and that of related proteins are evaluated. Next, the properties of the binding pocket are thoroughly explored, and areas are sought where an optimal binding is to be expected. Experimental techniques as well as computer methods are employed to discover a lead structure from a screening library (Chap. 7, “Screening Technologies for Lead Structure Discovery”). Alternatively, approaches are also applied that begin with a small molecular “seed” in the binding pocket, which is then allowed to “grow” to a potent ligand by using a stepwise iterative design. This approach uses fast docking techniques that propose relevant binding geometries. The geometries are evaluated with a scoring function, which estimates whether they are energetically favorable.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 649.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 949.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Bibliography

General Literature

  • Beddell CR (ed) (1992) The design of drugs to macromolecular targets. Wiley, Chichester

    Google Scholar 

  • Böhm HJ, Schneider G (2006) Molecular recognition in protein–ligand interactions. In: Mannhold R, Kubinyi H, Folkers G (eds) Methods and principles in medicinal chemistry, vol 19. Wiley-VCH, Weinheim

    Google Scholar 

  • Böhm HJ (1993) Ligand design. In: Kubinyi H (ed) 3D QSAR in drug design. Leiden, Escom, pp 386–405

    Google Scholar 

  • Borman S (1992) New 3-D search and de novo design techniques aid drug development. Chem Eng News 10:18–26

    Article  Google Scholar 

  • Branden C, Tooze J (1999) Introduction to protein structure, 2nd edn. Garland, New York

    Google Scholar 

  • Goodford P (1984) Drug design by the method of receptor fit. J Med Chem 27:557–564

    Article  CAS  Google Scholar 

  • Greer J, Erickson JW, Baldwin JJ, Varney MD (1994) Application of the three-dimensional structures of protein target molecules in structure-based drug design. J Med Chem 37:1035–1054

    Article  PubMed  CAS  Google Scholar 

  • Hubbard TJP, Lesk AM (1995) Modelling protein structures. In: Goodfellow JM (ed) Computer modelling in molecular biology. Weinheim, VCH

    Google Scholar 

  • Hutchins C, Greer J (1991) Comparative modeling of proteins in the design of novel renin inhibitors. Crit Rev Biochem Molec Biol 26:77–127

    Article  CAS  Google Scholar 

  • Kuntz ID, Meng EC, Shoichet BK (1994) Structure-based molecular design. Acc Chem Res 27:117–123

    Article  CAS  Google Scholar 

  • Kuntz ID (1992) Structure-based strategies for drug design and discovery. Science 257:1078–1082

    Article  PubMed  CAS  Google Scholar 

  • Martin YC (1992) 3D database searching in drug design. J Med Chem 35:2145–2154

    Article  PubMed  CAS  Google Scholar 

  • Müller K (1995) De novo design. In: Anderson PS, Kenyon GL, Marshall GR (eds) Persp drug discovery and de-sign, vol 3. Escom, Leiden

    Google Scholar 

  • Schneider G, Baringhaus KH (2008) Molecular design. Wiley-VCH, Weinheim

    Google Scholar 

Special Literature

  • Böhm HJ (1992a) LUDI: rule-based automatic design of new substituents for enzyme inhibitor leads. J Comp-Aided Molec Des 6:593–606

    Article  Google Scholar 

  • Böhm HJ (1992b) The computer program Ludi: a new method for the de novo design of enzyme inhibitors. J Comp-Aided Molec Des 6:61–78

    Article  Google Scholar 

  • Henderson R, Baldwin JM, Ceska TA, Zemlin F, Beckmann E, Downing KH (1990) Model of the structure of bacteriorhodopsin based on high-resolution electron cryo-microscopy. J Mol Biol 213:899–929

    Article  PubMed  CAS  Google Scholar 

  • Hibert M, Trumpp-Kallmeyer S, Hoflack J, Bruinvels A (1993) This is not a G-protein-coupled receptor. Trends Pharm Sci 14:7–12

    Article  PubMed  CAS  Google Scholar 

  • Hoflack J, Trumpp-Kallmeyer S, Hibert M (1994) Re-evaluation of bacteriorhodopsin as a model for G-protein-coupled receptors. Trends Pharm Sci 15:7–9

    Article  PubMed  CAS  Google Scholar 

  • Overington J, Johnson MS, Sali A, Blundell TL (1990) Tertiary structural constraints on protein evolutionary diversity: templates, key residues and structure prediction. Proc Roy Soc Lond B 241:132–145

    Article  CAS  Google Scholar 

  • Ring CS et al (1993) Structure-based inhibitor design by using protein models for the development of antiparasitic agents. Proc Natl Acad Sci 90:3583–3587

    Article  PubMed  CAS  Google Scholar 

  • Sali A, Blundell TL (1990) Definition of general topological equivalence in protein structures. J Mol Biol 212:403–428

    Article  PubMed  CAS  Google Scholar 

  • Schertler GFX, Villa C, Henderson R (1993) Projection structure of Rhodopsin. Nature 362:770–772

    Article  PubMed  CAS  Google Scholar 

  • Travis J (1993) Proteins and organic solvents make an eye-opening mix. Science 262:1374

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag Berlin Heidelberg

About this entry

Cite this entry

Klebe, G. (2013). Protein Modeling and Structure-Based Drug Design. In: Klebe, G. (eds) Drug Design. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-17907-5_20

Download citation

Publish with us

Policies and ethics